Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO

Stock Information for Aspira Women's Health Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aspira Women's Health Inc.

Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award
Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results
Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®
Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024
Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health
Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch®

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.